Marker levels of the adnexal masses 95% CI | Download Table
Human Epididymis Protein 4 (HE4) Is a Secreted Glycoprotein that Is Overexpressed by Serous and Endometrioid Ovarian Carcinomas | Cancer Research
SciELO - Brasil - A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses A comparison of CA125, HE4, risk ovarian
Serum HE4 and diagnosis of ovarian cancer in postmenopausal women with adnexal masses - American Journal of Obstetrics & Gynecology
Tumor Marker Control | Fujirebio
![PDF] HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bb4db523eb74d476a02524b225eb0835b20657d2/7-Table4-1.png "PDF] HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases | Semantic Scholar")
PDF] HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases | Semantic Scholar
Clinical significance of circulating tumor cell related markers in patients with epithelial ovarian cancer before and after adjuvant chemotherapy | Scientific Reports
Reference ranges of HE4 and CA125 according to age group | Download Table
![PDF] HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bb4db523eb74d476a02524b225eb0835b20657d2/6-Table3-1.png "PDF] HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases | Semantic Scholar")
PDF] HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases | Semantic Scholar
The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer
Clinical analysis of four serum tumor markers in 458 patients with ova | CMAR
Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response | Diagnostic Pathology | Full Text
PLOS ONE: Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer
differences between HE4, CA125, and ROMA values and sensitivity, PPV,... | Download Scientific Diagram
Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125 - ScienceDirect
Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library
Which Tumor Marker Can Be Used to Assess Stage, Prognosis, Response to Treatment? | ONS Voice
Tumor marker (composed of CA125 and HE4) after surgery, during... | Download Scientific Diagram
HE4 tumor marker concentration in neoplastic peritoneal effusion and in peritoneal fluid associated with benign gynecological diseases | Journal of Ovarian Research | Full Text
Table 2 from Determination of the Reference Values of the Tumor Marker HE4 in Female Population of Canton Sarajevo | Semantic Scholar
Clinical analysis of four serum tumor markers in 458 patients with ova | CMAR
PLOS ONE: Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer
HE4 Tissue Expression and Serum HE4 Levels in Healthy Individuals and Patients with Benign or Malignant Tumors: A Systematic Review | Cancer Epidemiology, Biomarkers & Prevention
